tiprankstipranks
Kaken Pharmaceutical Co Ltd (JP:4521)
:4521
Japanese Market

Kaken Pharmaceutical Co (4521) Income Statement

Compare
0 Followers

Kaken Pharmaceutical Co Income Statement

Last quarter (Q1 2025), Kaken Pharmaceutical Co's total revenue was ¥18.25B, an increase of 0.57% from the same quarter last year. In Q1, Kaken Pharmaceutical Co's net income was ¥1.75B. See Kaken Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 72.04B¥ 72.98B¥ 76.03B¥ 74.98B¥ 89.23B
Gross Profit
¥ 38.54B¥ 39.56B¥ 41.58B¥ 40.91B¥ 50.48B
Operating Expenses
¥ 29.03B¥ 31.55B¥ 24.51B¥ 23.11B¥ 23.97B
Depreciation and Amortization
¥ 2.75B¥ 2.57B¥ 2.48B¥ 2.32B¥ 2.76B
EBITDA
¥ 12.57B¥ 10.57B¥ 16.38B¥ 20.11B¥ 29.37B
Operating Income
¥ 9.51B¥ 8.00B¥ 17.06B¥ 17.79B¥ 26.51B
Other Income/Expenses
¥ 283.00M¥ -1.18B¥ -3.18B¥ 869.00M¥ 80.00M
Pretax Income
¥ 9.80B¥ 6.82B¥ 13.88B¥ 18.66B¥ 26.59B
Net Income
¥ 8.03B¥ 5.44B¥ 9.55B¥ 13.40B¥ 19.37B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 212.66¥ 144.79¥ 251.44¥ 347.37¥ 494.89
Diluted EPS
¥ 212.66¥ 144.79¥ 251.44¥ 347.37¥ 494.89
Weighted Average Shares Outstanding
37.74M 37.57M 37.98M 38.59M 39.14M
Weighted Average Shares Outstanding (Diluted)
37.74M 37.57M 37.98M 38.59M 39.14M
Currency in JPY

Kaken Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis